The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Millennium
Stock and Other Ownership Interests - Millennium
Patents, Royalties, Other Intellectual Property - Millennium
Ixazomib-dexamethasone (Ixa-Dex) vs physician’s choice (PC) in relapsed/refractory (RR) primary systemic AL amyloidosis (AL) patients (pts) by prior proteasome inhibitor (PI) exposure in the phase III TOURMALINE-AL1 trial.
 
Efstathios Kastritis
Honoraria - Amgen; Genesis Pharma; Janssen Oncology; Pfizer; Prothena; Takeda
Consulting or Advisory Role - Amgen; Genesis Pharma; Janssen Oncology; Pfizer; Prothena; Takeda
Research Funding - Amgen (Inst); Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Genesis Pharma; Janssen Oncology; Pfizer; Takeda
 
Angela Dispenzieri
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Prothena; Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
Ashutosh D. Wechalekar
Honoraria - Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Research Funding - Amgen
 
Stefan O. Schönland
Honoraria - Janssen; Prothena
Consulting or Advisory Role - Janssen; Prothena; Takeda
Research Funding - Janssen; Prothena
Travel, Accommodations, Expenses - Janssen; Merck Sharp & Dohme; Prothena; Sanofi; Takeda
 
Kihyun Kim
Honoraria - Amgen; Celgene; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Research Funding - Abbvie; Amgen; Celgene; Janssen; Takeda
 
Vaishali Sanchorawala
Consulting or Advisory Role - Abbvie; Caelum Biosciences; Janssen Research & Development; Proclara
Research Funding - Celgene (Inst); Janssen (Inst); Oncopeptides (Inst); Prothena (Inst); Takeda (Inst)
 
Heather Jolie Landau
Consulting or Advisory Role - Caelum Biosciences; Celgene; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Takeda
Research Funding - Takeda
 
Fiona Kwok
No Relationships to Disclose
 
Kenshi Suzuki
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Ono Pharmaceutical; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Research Funding - Celgene
 
Ray Comenzo
Consulting or Advisory Role - Janssen Oncology; Sanofi/Aventis; Takeda
Research Funding - Janssen Oncology
Patents, Royalties, Other Intellectual Property - TMC534 siRNA to knockdown Ig expression
 
Giovanni Palladini
Honoraria - Janssen
Consulting or Advisory Role - Janssen
Travel, Accommodations, Expenses - Celgene
 
Deborah Berg
No Relationships to Disclose
 
Guohui Liu
Employment - Millennium
 
Arun Kumar
Employment - Millennium
Stock and Other Ownership Interests - Millennium
 
Douglas V. Faller
Employment - Millennium
Leadership - Viracta Therapeutics
Stock and Other Ownership Interests - Viracta Therapeutics
Patents, Royalties, Other Intellectual Property - Viracta Therapeutics
 
Giampaolo Merlini
Travel, Accommodations, Expenses - Janssen